Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.
The proposed rule would add sections 229.1001-1005 to the Texas Health and Safety Code and would require the statement “WARNING: This product contains an ingredient that is not recommended for human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback